Immunological Genetic Molecular and pathological Correlates with Clinical and Treatment Outcome in Patients With Renal Cell Carcinoma
T
Theodore Logan, MD
Primary Investigator
Administratively Closed
18 years - 100 years
All
Phase
N/A
1000 participants needed
4 Locations
Brief description of study
The major purposes of this research study is to obtain blood and tissue samples from patients diagnosed with kidney cancer and/or tissue samples from patients undergoing surgery for their kidney cancer and to obtain clinical information.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Renal Cell Carcinoma, Cancer
-
Age: 18 years - 100 years
-
Gender: All
Inclusion Criteria
- Patients must have documented or suspected renal cell cancer.
Updated on
04 Aug 2025.
Study ID: IUCRO-0049, 1011004244
